28
nanotimes
Companies Facts
E Ink reported an EPS of NT$3.81, thanks to the fast- growing product demand, continuous R&D, and well executed cross-group synergy.
“In 2010 we achieved several key milestones,” said Dr. Scott Liu, Chairman, E Ink Holdings, Inc. “We tripled the number of ePaper displays as shipped in 2009 for the eReader market alone, launched two new ePaper display platforms, E Ink Pearl™ and E Ink Triton™ and we have had strong demand from the Tablet PC market for our FFS technology-based LCD products.”
http://www.e-ink.com
E
PIR Technologies, Inc. have repeatedly fabricated high efficiency polycrystalline cadmium tellu-
ride (CdTe) solar cells on commercial glass sub- strates. According to Dr. Siva Sivananthan, founder and CEO of EPIR Technologies, “EPIR has been collaborating closely with a team of scientists from National Renewable Energy Laboratory (NREL). Toge- ther we developed a CdTe solar cell with a maximum of 15.2% efficiency.” Dr. Sivananthan added, “The combination of EPIR’s expertise in CdTe materials and NREL’s expertise in CdTe solar cell device tech- nology has empowered us to achieve these excellent results in a short timeframe.”
According to Dr. Chollada Gilmore, EPIR’s CdTe Solar Cell Technical Lead, “Our champion cell effici- ency was officially verified by NREL at 15.2 % effici- ency. The high efficiency was driven by a fill factor of 77.6%, which is one of the highest fill factor values ever recorded for this type of solar cell. These results are significant because our solar cells were fabrica- ted using inexpensive commercial TEC-series glass substrates as opposed to technical-grade glass which
is commonly used in champion cell fabrication.” EPIR Technologies, Inc. is a pioneer of single crystal II-VI photovoltaic materials and a global leader in the field of infrared sensors and imaging.
http://www.epir.com
E
vonik Industries formally acquired the entire RESOMER®
business of Boehringer Ingelheim
Pharma GmbH & Co. KG on March 1, 2011. This acquisition involved transferring the entire product portfolio comprising standard and customer-specific polymers for medical applications and pharmaceuti- cal formulations to Evonik‘s Pharma Polymers Busi- ness Line.
The purchase agreement was signed in December 2010. Based on its polymer platform EUDRAGIT®
,
the Pharma Polymers Business Line is developing and researching customer-specific solutions for oral delivery forms. By acquiring the new RESOMER® Product Line, Pharma Polymers is opening up an application field in parenteral delivery forms, for example, for formulating innovative biotechnological active substances.
Furthermore, ACRIFIX® 1R 9019 Solar adhesive is
available immediately for bonding applications in furniture, store fixtures and exhibition stands. Evo- nik originally developed this product for use in solar applications of high requirements in terms of creating a premium appearance. ACRIFIX 1R 9019 Solar is a UV-curing polymerization adhesive. Its merits are that it is ideal for bonding large surfaces, geometri- cally complicated surfaces, T-joints and butt joints.
http://www.evonik.com
11-02/03 :: February / March 2011
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95